DNA methylation of dermal MSCs in psoriasis: Identification of epigenetically dysregulated genes

Journal of Dermatological Science

Volumn 72, Issue 2, 2013, Pages 103-109

  Hou, Ruixia ^a   Yin, Guohua ^a   An, Peng ^b   Wang, Chunfang ^c   Liu, Ruifeng ^a   Yang, Yuanwen ^a   Yan, Xin ^a   Li, Junqin ^a   Li, Xinhua ^a   Zhang, Kaiming ^a  

^a Taiyuan Central Hospital   (China)

^b QINGHAI UNIVERSITY   (China)

^c SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Dermal tissue; Gene dysfunction; Mesenchymal stem cells; Microarray; Promoter methylation; Psoriasis

Indexed keywords

CELL MARKER; CELL SURFACE RECEPTOR; GENOMIC DNA;

ADIPOCYTE; ADOLESCENT; ADULT; ANGIOGENESIS; ARTICLE; CACNA2D3 GENE; CBX4 GENE; CELL ADHESION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EPIDERMIS CELL; EPIGENETICS; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INTRACELLULAR SIGNALING; MALE; MESENCHYMAL STEM CELL; MOLECULAR MECHANICS; NRP2 GENE; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PSORIASIS; S100A10 GENE; SKIN CELL; SRF GENE; STIMULUS RESPONSE; TCL1B GENE; VASH1 GENE; CELL MEMBRANE; CYTOLOGY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; IMMUNE SYSTEM; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); NUCLEIC ACID HYBRIDIZATION; SKIN; YOUNG ADULT;

ADIPOCYTES; ADOLESCENT; ADULT; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNE SYSTEM; INFLAMMATION; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOBLASTS; PROMOTER REGIONS, GENETIC; PSORIASIS; SKIN; YOUNG ADULT;

EID: 84885027710     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.07.002     Document Type: Article

References (38)

1. Jain S., Kaur I.R., Das S., Bhattacharya S.N., Singh A. T helper 1 to T helper 2 shift in cytokine expression: an autoregulatory process in superantigen-associated psoriasis progression?. J Med Microbiol 2009, 58:180-184.
2. Prinz J.C. The role of T cells in psoriasis. J Eur Acad Dermatol Venereol 2003, 17:257-270.
3. Zhang X.J., Huang W., Yang S., Sun L.D., Zhang F.Y., Zhu Q.X., et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet 2009, 41:205-210.
4. de Cid R., Riveira-Munoz E., Zeeuwen P.L., Robarge J., Liao W., Dannahuser E.N., et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 2009, 41:211-215.
5. Liu Y., Helms C., Liao W., Zaba L.C., Duan S., Gardner J., et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 2008, 4:e1000041.
6. Sun L.D., Cheng H., Wang Z.X., Zhang A.P., Wang P.G., Xu J.H., et al. Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat Genet 2010, 42:1005-1009.
7. Grjibovski A.M., Olsen A.O., Magnus P., Harris J.R. Psoriasis in Norwegian twins: contribution of genetic and environmental effects. J Eur Acad Dermatol Venereol 2007, 21:1337-1343.
8. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843.
9. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002, 30:42-48.
10. Spaggiari G.M., Capobianco A., Becchetti S., Mingari M.C., Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006, 107:1484-1490.
11. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
12. Beyth S., Borovsky Z., Mevorach D., Liebergerall M., Gazit Z., Aslan H., et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005, 105:2214-2219.
13. Liu Y., Han Z.P., Zhang S.S., Jing Y.Y., Bu X.X., Wang C.Y., et al. Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. J Biol Chem 2011, 286:25007-25015.
14. Rho S.B., Dong S.M., Kang S., Seo S.S., Yoo C.W., Lee D.O., et al. Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis. Carcinogenesis 2008, 29:2106-2111.
15. Orciani M., Campanati A., Salvolini E., Lucarini G., Di Benedetto G., Offidani A., et al. The mesenchymal stem cell profile in psoriasis. Br J Dermatol 2011, 165:585-592.
16. Campanati A., Orciani M., Gorbi S., Regoli F., Di Primio R., Offidani A. Effect of biologic therapies targeting tumour necrosis factor-α on cutaneous mesenchymal stem cells in psoriasis. Br J Dermatol 2012, 167:68-76.
17. Zhang K., Liu R., Yin G., Li X., Li J., Zhang J. Differential cytokine secretion of cultured bone marrow stromal cells from patients with psoriasis and healthy volunteers. Eur J Dermatol 2010, 20:49-53.
18. Richardson B. DNA methylation and autoimmune disease. Clin Immunol 2003, 109:72-79.
19. Wu X., Rauch T.A., Zhong X., Bennett W.P., Latif F., Krex D., et al. CpG island hypermethylation in human astrocytomas. Cancer Res 2010, 70:2718-2727.
20. Koga Y., Pelizzola M., Cheng E., Krauthammer M., Sznol M., Ariyan S., et al. Genome-wide screen of promoter methylation identifies novel markers in melanoma. Genome Res 2009, 19:1462-1470.
21. Chen M., Chen Z.Q., Cui P.G., Yao X., Li Y.M., Li A.S., et al. The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance. Br J Dermatol 2008, 158:987-993.
22. Zhang K., Zhang R., Li X., Yin G., Niu X., Hou R. The mRNA expression and promotermethylation status of the p16 gene in colony-forming cells with high proliferative potential in patients with psoriasis. Clin Exp Dermatol 2007, 32:702-708.
23. Zhang K., Zhang R., Li X., Yin G., Niu X. Promoter methylation status of p15 and p21 genes in HPP-CFCs of bone marrow of patients with psoriasis. Eur J Dermatol 2008, 19:141-146.
24. Han J., Park S.G., Bae J.B., Choi J., Lyu J.M., Park S.H., et al. The characteristics of genome-wide DNA methylation in naïve CD4+ T cells of patients with psoriasis or atopic dermatitis. Biochem Biophys Res Commun 2012, 422:157-163.
25. Gervin K., Vigeland M.D., Mattingsdal M., Hammerø M., Nygård H., Olsen A.O., et al. DNA methylation and gene expression changes in monozygotic twins discordant for psoriasis: identification of epigenetically dysregulated genes. PLoS Genet 2012, 8:e1002454.
26. Cheng H., Qiu L., Zhang H., Cheng M., Li W., Zhao X., et al. Arsenic trioxide promotes senescence and regulates the balance of adipogenic and osteogenic differentiation in human mesenchymal stem cells. Acta Biochim Biophys Sin 2011, 43:204-209.
27. Robertson K.D. DNA methylation and human disease. Nat Rev Genet 2005, 6:597-610.
28. Nemeth K., Keane-Myers A., Brown J.M., Metcalfe D.D., Gorham J.D., Bundoc V.G., et al. Bone marrow stromal cells use TGF-β to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci USA 2010, 107:5652-5657.
29. Groh M.E., Maitra B., Szekely E., Koç O.N. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol 2005, 33:928-934.
30. Batten P., Sarathchandra P., Antoniw J.W., Tay S.S., Lowdell M.W., Taylor P.M., et al. Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. Tissue Eng 2006, 12:2263-2273.
31. Ryan J.M., Barry F.P., Murphy J.M., Mahon B.P. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond.) 2005, 2:8.
32. Ren G., Zhang L., Zhao X., Xu G., Zhang Y., Roberts A.I., et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008, 2:141-150.
33. Luis N.M., Morey L., Mejetta S., Pascual G., Janich P., Kuebler B., et al. Regulation of human epidermal stem cell proliferation and senescence requires polycomb-dependent and -independent functions of Cbx4. Cell Stem Cell 2011, 2(9):233-246.
34. Koegel H., von Tobel L., Schäfer M., Alberti S., Kremmer E., Mauch C., et al. Loss of serum response factor in keratinocytes results in hyperproliferative skin disease in mice. J Clin Invest 2009, 119:899-910.
35. Sulpice E., Plouët J., Bergé M., Allanic D., Tobelem G., Merkulova-Rainon T. Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity. Blood 2008, 111:2036-2045.
36. Watanabe K., Hasegawa Y., Yamashita H., Shimizu K., Ding Y., Abe M., et al. Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis. J Clin Invest 2004, 114:898-907.
37. Broome A.M., Ryan D., Eckert R.L. S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem 2003, 51(5):675-685.
38. O'Connell P.A., Surette A.P., Liwski R.S., Svenningsson P., Waisman D.M. S100A10 regulates plasminogen-dependent macrophage invasion. Blood 2010, 116(7):1136-1146.